Miriam Verwei

2.2k total citations
24 papers, 1.3k citations indexed

About

Miriam Verwei is a scholar working on Surgery, Health, Toxicology and Mutagenesis and Rheumatology. According to data from OpenAlex, Miriam Verwei has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Health, Toxicology and Mutagenesis and 7 papers in Rheumatology. Recurrent topics in Miriam Verwei's work include Effects and risks of endocrine disrupting chemicals (7 papers), Esophageal and GI Pathology (7 papers) and Folate and B Vitamins Research (7 papers). Miriam Verwei is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (7 papers), Esophageal and GI Pathology (7 papers) and Folate and B Vitamins Research (7 papers). Miriam Verwei collaborates with scholars based in Netherlands, Sweden and United Kingdom. Miriam Verwei's co-authors include R. Havenaar, Ivonne M.C.M. Rietjens, Jochem Louisse, Johannes J.M. van de Sandt, Bas J. Blaauboer, Mans Minekus, Andreas P. Freidig, Evelijn Zeijdner, Cyrille Krul and Evita van de Steeg and has published in prestigious journals such as Journal of Nutrition, Trends in Food Science & Technology and International Journal of Pharmaceutics.

In The Last Decade

Miriam Verwei

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miriam Verwei Netherlands	19	339	262	224	198	140	24	1.3k
Bruce M. Berger United States	5	132 0.4×	369 1.4×	65 0.3×	185 0.9×	58 0.4×	9	1.6k
Walter D. Wosilait United States	20	42 0.1×	809 3.1×	127 0.6×	114 0.6×	104 0.7×	66	1.7k
G Fabre France	16	69 0.2×	439 1.7×	45 0.2×	565 2.9×	77 0.6×	26	1.6k
Silvia Miret Netherlands	13	35 0.1×	268 1.0×	149 0.7×	70 0.4×	45 0.3×	16	1.8k
R. Ayesh United Kingdom	20	33 0.1×	556 2.1×	80 0.4×	214 1.1×	196 1.4×	30	1.4k
Ulrike Bernauer Germany	17	30 0.1×	181 0.7×	272 1.2×	83 0.4×	223 1.6×	40	851
Poh‐Gek Forkert Canada	23	110 0.3×	431 1.6×	174 0.8×	168 0.8×	384 2.7×	69	1.5k
Alison E.M. Vickers United States	23	39 0.1×	443 1.7×	96 0.4×	330 1.7×	126 0.9×	55	1.5k
Venkatesh Pooladanda India	19	86 0.3×	380 1.5×	53 0.2×	100 0.5×	42 0.3×	32	1.6k
Melvin D. Reuber United States	24	42 0.1×	580 2.2×	322 1.4×	191 1.0×	604 4.3×	102	1.8k

Countries citing papers authored by Miriam Verwei

Since Specialization

Citations

This map shows the geographic impact of Miriam Verwei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Verwei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Verwei more than expected).

Fields of papers citing papers by Miriam Verwei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Verwei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Verwei. The network helps show where Miriam Verwei may publish in the future.

Co-authorship network of co-authors of Miriam Verwei

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Verwei. A scholar is included among the top collaborators of Miriam Verwei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Verwei. Miriam Verwei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kubbinga, Marlies, et al.. (2019). The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir. European Journal of Pharmaceutics and Biopharmaceutics. 136. 147–155. 17 indexed citations

Verwei, Miriam, Mans Minekus, Evelijn Zeijdner, Ronald Schilderink, & R. Havenaar. (2015). Evaluation of two dynamic in vitro models simulating fasted and fed state conditions in the upper gastrointestinal tract (TIM-1 and tiny-TIM) for investigating the bioaccessibility of pharmaceutical compounds from oral dosage forms. International Journal of Pharmaceutics. 498(1-2). 178–186. 90 indexed citations

Bosgra, Sieto, Evita van de Steeg, Maria L.H. Vlaming, et al.. (2014). Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling. European Journal of Pharmaceutical Sciences. 65. 156–166. 63 indexed citations

Louisse, Jochem, Sieto Bosgra, Bas J. Blaauboer, Ivonne M.C.M. Rietjens, & Miriam Verwei. (2014). Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling. Archives of Toxicology. 89(7). 1135–1148. 64 indexed citations

Kostewicz, Edmund, Bertil Abrahamsson, Marcus E. Brewster, et al.. (2013). In vitro models for the prediction of in vivo performance of oral dosage forms. European Journal of Pharmaceutical Sciences. 57. 342–366. 299 indexed citations

Steeg, Evita van de, Rick Greupink, Kitty Verhoeckx, et al.. (2012). Drug-Drug Interactions between Rosuvastatin and Oral Antidiabetic Drugs Occurring at the Level of OATP1B1. Drug Metabolism and Disposition. 41(3). 592–601. 49 indexed citations

Louisse, Jochem, et al.. (2011). Relative developmental toxicity potencies of retinoids in the embryonic stem cell test compared with their relative potencies in in vivo and two other in vitro assays for developmental toxicity. Toxicology Letters. 203(1). 1–8. 27 indexed citations

Louisse, Jochem, Miriam Verwei, R.A. Woutersen, Bas J. Blaauboer, & Ivonne M.C.M. Rietjens. (2011). Towardin vitrobiomarkers for developmental toxicity and their extrapolation to thein vivosituation. Expert Opinion on Drug Metabolism & Toxicology. 8(1). 11–27. 25 indexed citations

Louisse, Jochem, et al.. (2010). Decrease of intracellular pH as possible mechanism of embryotoxicity of glycol ether alkoxyacetic acid metabolites. Toxicology and Applied Pharmacology. 245(2). 236–243. 12 indexed citations

10.

Louisse, Jochem, Esther de Jong, Johannes J.M. van de Sandt, et al.. (2010). The Use of In Vitro Toxicity Data and Physiologically Based Kinetic Modeling to Predict Dose-Response Curves for In Vivo Developmental Toxicity of Glycol Ethers in Rat and Man. Toxicological Sciences. 118(2). 470–484. 103 indexed citations

11.

Jong, Esther de, Jochem Louisse, Miriam Verwei, et al.. (2009). Relative Developmental Toxicity of Glycol Ether Alkoxy Acid Metabolites in the Embryonic Stem Cell Test as compared with the In Vivo Potency of their Parent Compounds. Toxicological Sciences. 110(1). 117–124. 52 indexed citations

12.

Freidig, Andreas P., Susan Dekkers, Miriam Verwei, et al.. (2007). Development of a QSAR for worst case estimates of acute toxicity of chemically reactive compounds. Toxicology Letters. 170(3). 214–222. 24 indexed citations

13.

Krüse, Jacob, B.M. Kulig, Miriam Verwei, et al.. (2007). Model studies for evaluating the neurobehavioral effects of complex hydrocarbon solvents. NeuroToxicology. 28(4). 751–760. 19 indexed citations

14.

Verwei, Miriam, Andreas P. Freidig, R. Havenaar, & John P. Groten. (2006). Predicted Serum Folate Concentrations Based on In Vitro Studies and Kinetic Modeling are Consistent with Measured Folate Concentrations in Humans. Journal of Nutrition. 136(12). 3074–3078. 42 indexed citations

15.

Verwei, Miriam, Johan A. van Burgsteden, Cyrille Krul, Johannes J.M. van de Sandt, & Andreas P. Freidig. (2006). Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling. Toxicology Letters. 165(1). 79–87. 73 indexed citations

16.

Verwei, Miriam, C.E. West, Trinette van Vliet, et al.. (2005). Bioavailability of folic acid from fortified pasteurised and UHT-treated milk in humans. European Journal of Clinical Nutrition. 59(8). 906–913. 22 indexed citations

17.

Verwei, Miriam, et al.. (2005). The effect of folate-binding proteins on bioavailability of folate from milk products. Trends in Food Science & Technology. 16(6-7). 307–310. 16 indexed citations

18.

Verwei, Miriam, Henk van den Berg, R. Havenaar, & John P. Groten. (2004). Effect of folate–binding protein on intestinal transport of folic acid and 5–methyltetrahydrofolate across Caco–2 cells. European Journal of Nutrition. 44(4). 242–249. 24 indexed citations

19.

Verwei, Miriam, et al.. (2003). Folic Acid and 5-Methyltetrahydrofolate in Fortified Milk Are Bioaccessible as Determined in a Dynamic In Vitro Gastrointestinal Model. Journal of Nutrition. 133(7). 2377–2383. 86 indexed citations

20.

Witthöft, Cornelia M., et al.. (2003). Bioaccessibility of Folic Acid and (6S)-5-Methyltetrahydrofolate Decreases after the Addition of Folate-Binding Protein to Yogurt as Studied in a Dynamic In Vitro Gastrointestinal Model. Journal of Nutrition. 133(11). 3678–3683. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact